Kettering Health Hamilton (DSH360132)

Disproportionate share hospital, Ohio, calendar year 2025. Everything below is as the workbook stored it, with figures shown to the cent. Each section follows the Ohio Department of Health's template, in its order and words.

The name is HRSA's, from its public list of covered entities read on 11 November 2026. The workbook prints the 340B ID and no name.

About this workbook

340B ID
  • DSH360132 Kettering Health Hamilton (Disproportionate share hospital)
Reporting period as typed
January 1, 2025 - December 31, 2025
Form
Ohio Department of Health, ORC 3701.88 340B Covered Entity Reporting Template, calendar year 2025

Drugs dispensed in house

Drugs the covered entity dispensed through its own pharmacies.

Drugs dispensed in house, as stored, for Kettering Health Hamilton (DSH360132)
Row of the templateCommercial Insurance/Private InsuranceMedicareMedicaid (all states)Other Third-Party PayorUninsured/Self-PayTotal
Acquisition costAggregate Acquisition Cost for all 340B drugs dispensed by the Covered Entity$25,733$137,171$197,908$37,032$0$397,844
Payments receivedAggregate Payments Received for all 340B drugs dispensed by the Covered Entity$117,244$399,293$495,739$67,557$0$1,079,833
All prescriptionsTotal number of Prescriptions dispensed by the Covered Entity (340B and non-340B)14,6746,4417,0674,8532,07435,109
340B prescriptionsTotal number of Prescriptions dispensed by the Covered Entity (340B)1,3232,3341,4721,85506,984
Percentage that were 340BPercentage of total prescriptions that were 340B9.02%36.24%20.83%38.22%0%19.89%

Drugs dispensed through contract pharmacies

Drugs contract pharmacies dispensed on behalf of the covered entity.

Drugs dispensed through contract pharmacies, as stored, for Kettering Health Hamilton (DSH360132)
Row of the templateCommercial Insurance/Private InsuranceMedicareMedicaid (all states)Other Third-Party PayorUninsured/Self-PayIndeterminate (Explain)Total
Acquisition costAggregate Acquisition Cost for all 340B drugs dispensed by all Contract Pharmacies on behalf of the Covered Entity above:$388,827$1,581,577$258,276$43$0$0$2,228,723
Payments receivedAggregate Payments Received for all 340B drugs dispensed by all Contract Pharmacies on behalf of the Covered Entity above:$466,301$3,405,115$540,093$448$0$0$4,411,957
All prescriptionsTotal number of Prescriptions filled by all Contract Pharmacies on behalf of the Covered Entity (340B and non-340B):Withheldnext to a small count30048Withheldfewer than 60Explanation Below386
340B prescriptionsTotal number of 340B Prescriptions filled by all Contract Pharmacies on behalf of the Covered Entity:Withheldnext to a small count30048Withheldfewer than 600386
Percentage that were 340BPercentage of total Covered-Entity associated prescriptions that were 340B:Withheldwould show a small count100%100%Withheldwould show a small count#DIV/0!#VALUE!100%

Drugs administered

Drugs the covered entity administered, for example by infusion or injection.

Drugs administered, as stored, for Kettering Health Hamilton (DSH360132)
Row of the templateCommercial Insurance/Private InsuranceMedicareMedicaid (all states)Other Third-Party PayorUninsured/Self-PayTotal
Acquisition costAggregate Acquisition Cost for all 340B drugs administered by the Covered Entity$2,533,509$7,313,308$2,033,113$280,528$174,264$12,334,722
Actual paymentsAggregate Payments Received for all 340B drugs administered by the Covered Entity - Actual Payments$4,186,734$9,413,330$1,845,910$79,737$0$15,525,711
Estimated paymentsAggregate Payments Received for all 340B drugs administered by the Covered Entity - Estimated Payments*$0$0$0$0$0$0
Total paymentsAggregate Payments Received for all 340B drugs administered by the Covered Entity - TOTAL$4,186,734$9,413,330$1,845,910$79,737$0$15,525,711
All prescriptionsTotal number of Prescriptions administered by the Covered Entity (340B and non-340B)78,199260,250111,25611,69318,797480,195
340B prescriptionsTotal number of Prescriptions administered by the Covered Entity (340B)49,99190,97553,4735,31610,329210,084
Percentage that were 340BPercentage of total prescriptions that were 340B63.93%34.96%48.06%45.46%54.95%43.75%

Figures are shown to the cent. The downloads keep each figure exactly as it is written in the file, and the cell file lists the workbook cell each one was read from.

Cells marked Withheld. A count of prescriptions from 1 to 5 is never published, and neither is a figure that would let a reader work one out.

  • The figure is not withheld because it is small. Next to the printed totals it would let a reader work out a count of 1 to 5 in another cell.
  • The count of prescriptions is 1 to 5. A count that small is never published, here or in the data files.
  • The percentage would let a reader work out a count of 1 to 5 in another cell.

Costs of running the program

Amounts in US dollars, as the workbook stores them.

Costs, as stored, for Kettering Health Hamilton (DSH360132)
CostAmountCell
Contract pharmacies$464,574C46
Third-party administrators$122,825C47
Consultants$17,405C48
Software and IT-C49
Other outside costs-C50
Staffing$101,700C53
Internal IT-C54
Other internal costs-C55

Contract pharmacies

Number of contract pharmacies as typed
3

Explanation of the Indeterminate column, as typed

Per standard 340B software architecture, non-340B dispensing data is not captured or accessible to the Covered Entity for these contract locations. Total counts reflect 340B-cleared transactions only.

Uses of 340B funds

What the filer typed under the template's questions about how it uses the money 340B brings in. A dash or an empty cell is left out.

Narrative given where the entity cannot detail its uses, as typed

Kettering Health 340B Program Savings Narrative

The filer in the workbook

340B ID as typed
DSH360132
NPIs as typed
  • 1104867167
  • 1558668350

Cells outside the template

The filer typed text in cells the template does not ask for. They are listed as found, by cell.

Cells outside the template, as typed, for Kettering Health Hamilton (DSH360132)
CellText
C83Kettering Health participates in the federal 340B Drug Pricing Program as part of its commitment to improving the health and well-being of the communities it serves. The program allows eligible Kettering Health entities to purchase outpatient medications at reduced prices, generating savings that are reinvested to expand access to care, improve affordability, and strengthen patient services.
C84Consistent with federal guidance, 340B savings are not maintained as a separate fund but are integrated into the overall financial framework of Kettering Health. These resources are strategically deployed to directly support patient care initiatives, particularly for underserved, uninsured, and underinsured populations.
C87Demonstrated Patient and Community Impact in 2025
C88In 2025, Kettering Health’s patient assistance program supported in part by 340B savings—generated over $91.8 million in total patient support, reflecting a substantial investment in medication access and affordability.
C89Complementing these efforts, Kettering Health also provided significant levels of uncompensated care across the system, underscoring its role as a safety net provider:
C90Charity Care: $255.6 million
C91Bad Debt: $128.6 million
C92Total Uncompensated Care: $376.5 million
C93These figures highlight the magnitude of financial support provided to patients and communities and reinforce the critical role 340B savings play in sustaining these efforts.
C94Key patient assistance highlights include:
C95Infusion Support: More than $29.3 million in assistance
C96Specialty Pharmacy Programs: Over $48.5 million in total support
C97Ambulatory Care Assistance: Approximately $12.8 million
C98Together, these investments demonstrate how 340B-enabled resources are directly translated into meaningful financial relief and improved access to care.
C101Expanding Access to Care
C102Kettering Health uses 340B program savings to broaden access to essential healthcare services. These resources help offset the significant financial burden reflected in the $376.5 million in uncompensated care provided in 2025, enabling:
C103Continued care regardless of a patient’s ability to pay
C104Expansion of services in rural and underserved communities
C105Sustainability of critical programs that operate at a financial loss
C108Enhancing Medication Access and Affordability
C109Medication affordability remains a central focus of Kettering Health’s 340B strategy. The 2025 data reflect a comprehensive approach that includes:
C110Direct financial assistance to reduce patient out-of-pocket costs
C111Free drug replacement programs ensuring continuity of therapy
C112Copay support for high-cost infusion and specialty medications
C113Innovative tools such as the 340B Care Card program
C114These efforts reduce financial barriers and complement the system’s broader charity care and uncompensated care commitments.
C117Supporting and Expanding Clinical Services
C118The breadth of assistance across infusion, specialty, and ambulatory care settings reflects Kettering Health’s investment in comprehensive clinical services. 340B savings help support:
C119Advanced therapies for complex and chronic conditions
C120Specialty pharmacy management of high-cost medications
C121Integrated outpatient care models
C122These services are essential in managing the needs of patients who may otherwise contribute to uncompensated care if access were limited.
C125Addressing Social Determinants of Health
C126Kettering Health recognizes that financial hardship is a major barrier to care. The combination of $91.8 million in patient assistance and $376.5 million in uncompensated care demonstrates a system-wide commitment to reducing these barriers.
C127Additional support includes transportation, education, and care coordination services that ensure patients can access and adhere to treatment.
C130Investing in Workforce and Infrastructure
C131Delivering this level of patient and community support requires significant operational investment. 340B savings fund:
C132Clinical pharmacy teams and patient assistance coordinators
C133Infrastructure supporting specialty and infusion services
C134Technology systems for tracking and optimizing assistance
C135Compliance oversight and program integrity
C138Offsetting Financial Pressures and Sustaining Services
C139The scale of charity care and bad debt in 2025 illustrates the financial realities faced by Kettering Health. 340B savings help offset:
C140$255.6 million in charity care provided to patients in need
C141$128.6 million in bad debt associated with unpaid care
C142Reimbursement shortfalls and high-cost therapies
C143These resources are essential to sustaining access to care and maintaining critical services across the system.
C146Advancing Community and Population Health
C147Through strategic reinvestment of 340B savings, Kettering Health continues to improve community health outcomes by:
C148Reducing delays in care due to financial barriers
C149Improving medication adherence
C150Supporting chronic disease management
C151Expanding preventive care initiatives
C154Ensuring Program Integrity and Compliance
C155Kettering Health is committed to responsible stewardship of the 340B program. Program savings support:
C156Ongoing audits and monitoring
C157Staff education and compliance efforts
C158Policies and systems aligned with federal requirements
C161Summary
C162In 2025, Kettering Health demonstrated the impact of its mission-driven approach through:
C163$91.8 million in patient assistance programs
C164$376.5 million in total uncompensated care, including:
C165$255.6 million in charity care
C166$128.6 million in bad debt
C167340B program savings are a vital component enabling Kettering Health to sustain these efforts by:
C168Expanding access to care
C169Reducing financial barriers for patients
C170Supporting high-cost and specialized therapies
C171Strengthening clinical services and infrastructure
C172Through this reinvestment, Kettering Health continues to fulfill its mission of delivering compassionate, high-quality care while addressing the evolving needs of the communities it serves.

Differences in this workbook

No difference was found between this workbook's own figures by the rules in Methods.

Source

Workbook
Open DSH360132.xlsx on the Ohio Department of Health's website
Size
27 KB
Retrieved
16 November 2026
SHA-256
f1dfedb2a39e8cdb2e706ebab9b78c36599ab6a375bce48ced0e49e4c75910a9
How it was read
Two separate programs read each cell of the workbook, and a value is kept when their reads agree. The cells of this workbook are listed one by one in the dataset repository.